Celldex's market cap is currently $1.70B. The company's EPS TTM is $-0.85; its P/E ratio is ―; Celldex is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.90. See an overview of income statement, balance sheet, and cash flow financials.
